Polaryx Therapeutics, Inc. (PLYX)

NASDAQ: PLYX · Real-Time Price · USD

5.70

-0.42 (-6.86%)

At close: Apr 20, 2026, 4:00 PM EDT

6.03

+0.33 (5.79%)

Pre-market: Apr 21, 2026, 4:37 AM EDT

Polaryx Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	-	-	-	0.10
Net Debt / Equity Ratio	-1.13	-1.13	-0.98	0.10
Quick Ratio	8.50	8.50	15.99	0.00
Current Ratio	8.55	8.55	17.30	2.23
Return on Equity (ROE)	-193.70%	-193.70%	-1013.73%	-
Return on Assets (ROA)	-96.12%	-96.12%	-74.36%	-
Return on Capital Employed (ROCE)	-171.30%	-171.30%	-92.40%	-296.10%
Buyback Yield / Dilution	-32.81%	-32.81%	-219.94%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q